Target intelligence / Profile preview

Tetanus toxoid-specific B-cell receptors and T-cell receptors (TT-specific BCR/TCR)

Target
TT-specific BCR/TCR
Molecular classification
Receptor, Immunoglobulin superfamily
01

Overview

Tetanus toxoid-specific B-cell receptors (BCRs) and T-cell receptors (TCRs) are specialized surface proteins on lymphocytes responsible for recognizing the inactivated toxin of Clostridium tetani (StatPearls, 2023). These receptors play a critical role in the adaptive immune system by identifying the tetanus toxoid antigen presented during vaccination or infection (CDC, 2022). When these receptors bind to their specific epitopes, they initiate a cascade of cellular events including B-cell maturation into antibody-secreting plasma cells and T-cell activation for cytokine production and help (PubMed, PMID: 24610398). This process is the fundamental mechanism behind the efficacy of tetanus vaccines, which aim to generate long-lived memory B and T cells that can rapidly respond to future exposures (WHO, 2017). Because of the widespread use of tetanus vaccination, these receptors are also extensively utilized in clinical research as a benchmark for assessing human immune competence and the dynamics of immunological memory (PubMed, PMID: 31434705). The interaction between the toxoid and these receptors is essential for preventing the neuromuscular symptoms of tetanus, such as muscle spasms and respiratory failure (NIH, 2023).

Other names
Tetanus toxoid-reactive B-cell receptorsTetanus toxoid-reactive T-cell receptorsTT-specific immune receptorsAnti-tetanus toxoid receptors
02

Mechanism of action

Antigen-specific binding to B-cell and T-cell receptors triggers clonal expansion and differentiation of lymphocytes into effector and memory cells.

03

Biological functions

Immune responseAntigen recognitionLymphocyte activationImmunological memory
04

Disease associations

InfectionTetanus
05

Safety considerations

Hypersensitivity reactionsArthus-type reactionsInjection site pain and swellingBrachial neuritis
06

Interacting drugs

Tetanus toxoid vaccine

3 more in the full profile.

07

Biomarkers

Anti-tetanus toxoid IgG antibody titerTT-specific CD4+ T-cell frequencyTT-specific B-cell frequency

Beyond the preview

Go deeper on Tetanus toxoid-specific B-cell receptors and T-cell receptors (TT-specific BCR/TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus toxoid-specific B-cell receptors and T-cell receptors (TT-specific BCR/TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call